Dubai Investments’ wholly owned subsidiary Globalpharma has signed three MoUs with companies in Egypt and Jordan.

Mohammed Saeed Al Raqbani, General Manager, Dubai Investments Industries and Director for Globalpharma, attended the signing ceremony.

Raqbani said: “These signings also coincide with Globalpharma’s 25th anniversary in business this year and reiterates the company’s efforts in developing a more long-term, integrated approach to solidify competitiveness and stimulate growth region-wide.

“Globalpharma has articulated a robust business plan that will provide knowledge and technology transfer; we also see much opportunity to introduce, produce and market a pipeline of broadly diversified products to suit a diversified population.”

Globalpharma signed a partnership for technology transfer with the Egyptian company Nerhado on advanced manufacturing technology for production of medicines and nutritional supplements in the UAE.

The company also partnered with two Jordanian companies, Savvy Pharma and Itqan Pharma, to facilitate a knowledge transfer in the field of research and development of value-added medicines, thus expanding manufacturing and production.

Present at the signing ceremony was also Globalpharma’s board advisor Dr Mariam Galadari & General Manager Dr Basem Albarahmeh.